Purus Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$768K Sell
18,263
-420
-2% -$13.4K 0.21% 81
2026
Q1
$494K Sell
18,683
-178
-0.9% -$5.21K 0.16% 90
2025
Q4
$546K Buy
18,861
+25
+0.1% +$750 0.17% 82
2025
Q3
$523K Sell
18,836
-1,777
-9% -$44.9K 0.17% 82
2025
Q2
$502K Sell
20,613
-125
-0.6% -$2.74K 0.17% 83
2025
Q1
$431K Sell
20,738
-381
-2% -$9.57K 0.18% 81
2024
Q4
$497K Sell
21,119
-65,801
-76% -$1.62M 0.2% 74
2024
Q3
$2.23M Buy
86,920
+265
+0.3% +$6.75K 0.94% 27
2024
Q2
$2.03M Sell
86,655
-1,070
-1% -$27K 0.9% 28
2024
Q1
$2.52M Sell
87,725
-3,534
-4% -$106K 1.25% 21
2023
Q4
$2.99M Sell
91,259
-5,254
-5% -$143K 1.74% 17
2023
Q3
$2.69M Sell
96,513
-844
-0.9% -$27.6K 1.82% 16
2023
Q2
$3.32M Buy
97,357
+1,883
+2% +$59.2K 2.15% 13
2023
Q1
$2.87M Sell
95,474
-475
-0.5% -$14.7K 2.27% 13
2022
Q4
$2.71M Sell
95,949
-2,473
-3% -$78.5K 2.46% 10
2022
Q3
$3.23M Sell
98,422
-2,462
-2% -$90.4K 2.98% 9
2022
Q2
$3.18M Sell
100,884
-1,368
-1% -$47.8K 2.84% 11
2022
Q1
$4.7M Sell
102,252
-1,443
-1% -$68.8K 3.25% 10
2021
Q4
$6.35M Sell
103,695
-10,617
-9% -$734K 3.98% 5
2021
Q3
$8.54M Buy
114,312
+154
+0.1% +$12.9K 5.9% 2
2021
Q2
$10.6M Buy
114,158
+1,443
+1% +$123K 7.6% 2
2021
Q1
$10M Sell
112,715
-514
-0.5% -$51K 8.41% 2
2020
Q4
$10.6M Buy
+113,229
New +$9.02M 9.42% 2

Other funds holding ARKG

Purus Wealth Management's ARKG Position: Q2 2026 in Review

Purus Wealth Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 2.2% in Q2 2026, selling an estimated $13.4K and leaving 18,263 shares worth $768K. The position accounts for 0.21% of the portfolio, ranked #81.

Purus Wealth Management first reported a position in ARKG in Q4 2020 and has held it in 23 quarters since. The position peaked at $10.6M in Q2 2021. 36 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Purus Wealth Management held 18,263 shares of ARK Genomic Revolution ETF worth $768K as of Q2 2026.
  • Purus Wealth Management sold 420 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $13.4K.
  • ARK Genomic Revolution ETF made up 0.21% of Purus Wealth Management's portfolio in Q2 2026, its #81 holding.
  • Purus Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 23 quarters since.
  • Purus Wealth Management's ARK Genomic Revolution ETF position peaked at $10.6M in Q2 2021.
  • 36 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Purus Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.